| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/07/2009 | CA2286098C Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 07/03/2009 | CA2648406A1 Translocator component derivatives and uses thereof |
| 07/02/2009 | WO2009082607A2 Targeting lipids |
| 07/02/2009 | WO2009082606A2 Folate-irna conjugates |
| 07/02/2009 | WO2009082462A2 Sulfo-polymer powder and sulfo-polymer powder blends |
| 07/02/2009 | WO2009082354A1 Cross-linked hydrogel containing an active substance |
| 07/02/2009 | WO2009082227A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
| 07/02/2009 | WO2009082203A1 Liquid nucleotides/nucleosides-containing product |
| 07/02/2009 | WO2009081991A1 Therapeutic agent for cerebral ischemic injury |
| 07/02/2009 | WO2009081716A1 Spherical grain, method of producing the same and method of producing sustained release preparation |
| 07/02/2009 | WO2009081587A1 External preparation for skin |
| 07/02/2009 | WO2009080832A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | WO2009080831A1 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates |
| 07/02/2009 | WO2009080830A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | WO2009080823A2 Nerve growth factor conjugates and uses thereof |
| 07/02/2009 | WO2009080764A2 Oral or nasal administration of compounds comprising amino acid sequences |
| 07/02/2009 | WO2009080719A1 Vaccine |
| 07/02/2009 | WO2009080715A2 Vaccines for malaria |
| 07/02/2009 | WO2009080699A2 Peg-interferon-beta formulations |
| 07/02/2009 | WO2009080541A1 Antibody formulation |
| 07/02/2009 | WO2009080275A1 Extruded rod-shaped devices for controlled release of biological substances to humans and animals |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079910A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009079679A2 Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists |
| 07/02/2009 | WO2009063484A3 Stable pharmaceutical composition of lamotrigine |
| 07/02/2009 | WO2009061607A3 Water-immiscible materials as vehicles for drug delivery |
| 07/02/2009 | WO2009061105A3 Stabilized preparation containing coenzyme q10 and process for preparation thereof |
| 07/02/2009 | WO2009027844A3 Crf conjugates with extended half-lives |
| 07/02/2009 | WO2008068427A8 Anti-microorganism terpenic composition |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | WO2008025527A8 Method for the production of insulin-like growth factor-i |
| 07/02/2009 | US20090171264 Medical Devices Based On Poly(Vinyl Alcohol) |
| 07/02/2009 | US20090171077 Delivery of nucleic acid-like compounds |
| 07/02/2009 | US20090171075 Molecular transporter compositions comprising dendrimeric oligoguanidine with a triazine core that facilitate delivery into cells in vivo |
| 07/02/2009 | US20090170960 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 07/02/2009 | US20090170959 Polymer carrier |
| 07/02/2009 | US20090170958 Use of particular polymers or copolymers as surfactants for stabilizing latices |
| 07/02/2009 | US20090170944 Ophthalmic micellar compositions with enhanced stability |
| 07/02/2009 | US20090170811 Composition for treatment of a detached retina and method of prodution thereof |
| 07/02/2009 | US20090170768 Water-soluble carbon nanotube compositions for drug delivery and medicinal applications |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170761 Sustained release preparation of pro-insulin c-peptide |
| 07/02/2009 | US20090170705 Phyllosilicate formulations for the controlled release of active substances |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090169644 Antidandruff Shampoo |
| 07/02/2009 | US20090169639 Particles for injection and processes for forming the same |
| 07/02/2009 | US20090169629 Micellar compositions with ophthalmic applications |
| 07/02/2009 | US20090169624 Observing elution of compound from matrix comprising buffered detergents; assessing and controlling manufacturing process variability of drug eluting implantable devices such as cardiac leads |
| 07/02/2009 | US20090169621 Pharmaceutical excipient having improved compressibility |
| 07/02/2009 | US20090169611 Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications |
| 07/02/2009 | US20090169609 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/02/2009 | US20090169595 Controlled Release Polymeric Compositions of Bone Growth Promoting Compounds |
| 07/02/2009 | US20090169591 Medical articles for the treatment of tumors |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169566 Bioactive compositions |
| 07/02/2009 | US20090169559 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 07/02/2009 | US20090169532 Curable bone cement |
| 07/02/2009 | US20090169511 Mucosal Bioadhesive SLow Release Carrier for Delivering Active Principles |
| 07/02/2009 | US20090169506 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/02/2009 | US20090169500 Personal care compositions |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | US20090166903 Molded waveguides |
| 07/02/2009 | CA2738403A1 Domestic animal parasite-repellent device |
| 07/02/2009 | CA2712414A1 Pharmaceutical composition |
| 07/02/2009 | CA2710483A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | CA2710471A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | CA2710141A1 Ngf conjugates and uses thereof |
| 07/02/2009 | CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | CA2708869A1 Antibody formulation |
| 07/02/2009 | CA2708819A1 An erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof |
| 07/02/2009 | CA2708718A1 Vaccine |
| 07/02/2009 | CA2708716A1 Vaccines for malaria |
| 07/02/2009 | CA2708173A1 Targeting lipids |
| 07/02/2009 | CA2708171A1 Folate conjugates |
| 07/02/2009 | CA2706183A1 Cross-linked hydrogel containing an active substance |
| 07/02/2009 | CA2704268A1 Receptor targeting ligands |
| 07/01/2009 | EP2075011A2 Prodrugs Containing Bio-Cleavable Linkers |
| 07/01/2009 | EP2075010A1 Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof |
| 07/01/2009 | EP2075009A1 Medicinal cooling emulsions |
| 07/01/2009 | EP2074143A1 Altered antibodies |
| 07/01/2009 | EP2074137A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 07/01/2009 | EP2073850A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 07/01/2009 | EP2073849A2 Methods and compositions for gene therapy |
| 07/01/2009 | EP2073848A2 Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 07/01/2009 | EP2073847A2 Methods and materials for reducing risk of cold and/or flu |
| 07/01/2009 | EP2073834A2 Methods for administering long-lasting hypoglycemic agents |
| 07/01/2009 | EP2073832A2 Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
| 07/01/2009 | EP2073809A2 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 07/01/2009 | EP2073793A2 Compositions containing coenzyme q-10 in reduced form and dihydrolipoic acid |
| 07/01/2009 | EP2073792A2 Superporous hydrogels |
| 07/01/2009 | EP2073634A1 Stabilized prostaglandin e composition |
| 07/01/2009 | EP1713439B1 Pharmaceutical preparation for the oral cavity |
| 07/01/2009 | EP1613610B1 Benzo 1,2,5 oxadiazoles and benzo 1,2,5 thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 07/01/2009 | EP1565208B1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 07/01/2009 | EP1511721B1 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 07/01/2009 | EP1381367A4 Aripiprazole oral solution |
| 07/01/2009 | EP1359883A4 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia |
| 07/01/2009 | EP1263325B1 Embolic agents visible under ultrasound |
| 07/01/2009 | EP1250154B1 G-csf conjugates |